top of page
Profile
Join date: Nov 29, 2021
Posts (2)
Nov 10, 2021 ∙ 4 min
What, Me Worry? ROS1 patients find calm by managing stressors specific to ROS1 cancer
This article by Joyce Hoelting first appeared in the Fall 2021 ROS1derings (newsletter of The ROS1ders). The more researchers learn about...
240
0
2
Jan 5, 2017 ∙ 4 min
Patients’ Tips on How to Deal with Common Side Effects of Crizotinib (aka Xalkori)
Crizotinib, also known as Xalkori, is a targeted therapy medication prescribed to many patients with ROS1+ cancer. It can be a very...
684
0
Joyce Hoelting
Writer
More actions
bottom of page